80
Views
0
CrossRef citations to date
0
Altmetric
Research

Opportunities for extended community pharmacy services in United Arab Emirates: perception, practice, perceived barriers and willingness among community pharmacists

ORCID Icon, , &
Article: 24 | Received 30 Jul 2021, Accepted 04 Mar 2022, Published online: 04 Dec 2023

References

  • Ibrahim MIM. Assessment of medication dispensing and extended community pharmacy services. In:Izham MIM, Wertheimer A, Babar ZUD, editor.Social and administrative aspects of pharmacy in low-and middle-income countries. Amsterdam:Elsevier; 2018. p.295–309.
  • Solunke RS, Deshmukh MT, Mohire GN. Role of pharmacist in health care system. J Curr Pharm Res. 2017;7(2):2074–2081.
  • Newman TV, San-Juan-Rodriguez A, Parekh N, Swart EC, Klein-Fedyshin M, Shrank WH, Hernandez I. Impact of community pharmacist-led interventions in chronic disease management on clinical, utilization, and economic outcomes: An umbrella review. Res Social Adm Pharm. 2020;16(9):1155–1165.
  • Sadek MM, Elnour AA, Al Kalbani NM, Bhagavathula AS, Baraka MA, Aziz AM, Shehab A. Community pharmacy and the extended community pharmacist practice roles: the UAE experiences. Saudi Pharm J. 2016;24(5):563–570.
  • Blouin RA, Adams ML. The role of the pharmacist in health care: expanding and evolving. N C Med. 2017;78(3):165–167.
  • Awad A, Aabahussain E. Health promotion and education activities of community pharmacists in Kuwait. Pharm World Sci. 2010;32(2):146–153.
  • Ali M, Schifano F, Robinson P, Phillips G, Doherty L, Melnick P, Laming L, Sinclair A, Dhillon S. Impact of community pharmacy diabetes monitoring and education programme on diabetes management: a randomized controlled study. Diabet Med. 2012;29(9):e326–e333.
  • Krass I, Armour CL, Mitchell B, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24(6):677–683.
  • Närhi U, Airaksinen M, Tanskanen P, Erlund H. Therapeutic outcomes monitoring by community pharmacists for improving clinical outcomes in asthma. J Clin Pharm Ther. 2000;25(3):177–183.
  • Dokbua S, Dilokthornsakul P, Chaiyakunapruk N, Saini B, Krass I, Dhippayom T. Effects of an asthma self-management support service provided by community pharmacists: a systematic review and meta-analysis. J Manag Care Spec Pharm. 2018;24(11):1184–1196.
  • Sadek MM, Elnour AA, Al Kalbani NM, et al. Community pharmacy and the extended community pharmacist practice roles: The UAE experiences. Saudi Pharm J. 2016;24(5):563–570.
  • Marfo AF, Owusu-Daaku FT. Exploring the extended role of the community pharmacist in improving blood pressure control among hypertensive patients in a developing setting. J Pharm Policy Pract. 2017;10(1):39.
  • Inch J, Bond CM, Lee AJ, Scott A, Grant AM. Scottish community pharmacists’ current involvement in and attitudes towards ‘extended service’ provision: a national survey. Int J Pharm Pract. 2005;13(4):289–301.
  • Nordin N, Hassali MA, Sarriff A. A global picture of extended pharmacy services, perceptions and barriers toward its performance: a systematic review. Asian J Pharm Clin Res. 2017;10(11):417–427.
  • Giberson S, Yoder S, Lee MP. Improving patient and health system outcomes through advanced pharmacy practice. A Report to the US Surgeon General. Office of the Chief Pharmacist. US Public Health Service. 2011;44. https://jcpp.net/wp-content/uploads/2015/09/Improving-Patient-and-Health-System-Outcomes-through-Advanced-Pharmacy-Practice.pdf.
  • McDonald R, Cheraghi-Sohi S, Sanders C, Ashcroft D. Professional status in a changing world: the case of medicines use reviews in English community pharmacy. Soc Sci Med. 2010;71(3):451–458.
  • Bush J, Langley CA, Wilson KA. The corporatization of community pharmacy: implications for service provision, the public health function, and pharmacy’s claims to professional status in the United Kingdom. Res Social Adm Pharm. 2009;5(4):305–318.
  • El Hajj MS, Al-saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–343.
  • Abdi AM, Zarouri AT, Saloumi L, Basgut B. North Cyprus pharmacist’s cognition and practice of pharmaceutical care. J Pharm Res Int. 2018;21:1–9.
  • Hasan S, Sulieman H, Stewart K, Chapman CB, Hasan MY, Kong DC. Assessing patient satisfaction with community pharmacy in the UAE using a newly-validated tool. Res Social Adm Pharm. 2013;9(6):841–850.
  • Dameh M. Pharmacy in the United Arab Emirates. South Med Rev. 2009;2(1):15.
  • Hasan S, Sulieman H, Chapman CB, Stewart K, Kong DC. Community pharmacy services in the United Arab Emirates. Int J Pharm Pract. 2012;20(4):218–225.
  • Alzubaidi H, Saidawi W, Mc NK. Pharmacist views and pharmacy capacity to deliver professional services in the United Arab Emirates. Int J Clin Pharm. 2018;40(5):1106–1115.
  • Worldomenter. United Arab Emirates population. Available at https://www.worldometers.info/world-population/united-arab-emirates-population/.
  • Barkat K, Sbia R, Maouchi Y. Empirical evidence on the long and short run determinants of health expenditure in the Arab world. Q Rev Econ Finance. 2019;73:78–87.
  • Bernsten C, Björkman I, Caramona M, Crealey G, Frøkjær B, Grundberger E, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care. Drugs Aging. 2001;18(1):63–77.
  • Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–230.
  • Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30(3):211–215.
  • Qassim S, Metwaly Z, Shamsain M, Al HY. Reporting adverse drug reactions: evaluation of knowledge, attitude and practice among community pharmacists in UAE. IOSR J Pharm. 2014;22(30):31–40.
  • Qassim S, Metwaly Z, Shamsain M, AlHariri Y. Spontaneous reporting of adverse drug reactions in UAE: obstacles and motivation among community pharmacists. Int J Pharm Sci Res. 2014;5:4203–4208.
  • Hashmi FK, Hassali MA, Khalid A, Saleem F, Aljadhey H, Bashaar M. A qualitative study exploring perceptions and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan. BMC Health Serv Res. 2017;17(1):500.
  • Bryant L, Coster G, McCormick R. Community pharmacist perceptions of clinical medication reviews. J Prim Health Care. 2010;2(3):234–242.
  • Oparah AC, Eferakeya AE. Attitudes of Nigerian pharmacists towards pharmaceutical care. Pharm World Sci. 2005;27(3):208–214.
  • Yaghamei Maei F. Content validity and its estimation. J Med Educ. 2003;3(1):25–27.
  • Hallit S, Selwan CA, Salameh P. Primary health care policy and vision for community pharmacy and pharmacists in Lebanon. Pharma Pract (Granada). 2020;18(2):2003.
  • Abduelkarem AR. Extending the role of pharmacists in patient care: are pharmacists in developing nations ready to change? Pharmacol Pharm. 2014;5:856–875.
  • Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s National Pharmacy Database Project. Int J Pharm Pract. 2007;15(3):185–191.
  • Azhar S, Hassali M, Ibrahim M. Doctors’ perception and expectations of the role of the pharmacist in Punjab, Pakistan. Trop J Pharm Res. 2010;9(3).
  • Hashmi FK, Hassali MA, Saleem F, Babar Z. A qualitative study exploring perception and attitudes of community pharmacists about extended pharmacy services in Lahore, Pakistan. Value Health. 2016;19(7):A631.
  • Alexander KM, Divine HS, Hanna CR, Gokun Y, Freeman PR. Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists. J Am Pharm Assoc. 2014;54(5):510–517.
  • Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. Am J Health Syst Pharm. 2006;63(21):2144–2150.
  • Song M, Ung COL, Hu H, Wang Y. Community pharmacists’ perceptions about pharmaceutical care of OTC western medicine: a survey in Harbin of China. Int J Clin Pharm. 2015;37(6):1014–1020.
  • Sadia Shakeel W, Yasmin R, Ali H, Ibrahim S. Pharmacy student’s perception and attitude towards the course and scope of community pharmacy in Pakistan. J Pharm Biomed Sci. 2013;32(32):1400–1406.
  • Eades CE, Ferguson JS, O’Carroll RE. Public health in community pharmacy: a systematic review of pharmacist and consumer views. BMC Public Health. 2011;11(1):582.
  • Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–230.
  • Krska J, Veitch GB. Perceived factors influencing the development of primary care? Based pharmaceutical care in Scotland. Int J Pharm Pract. 2001;9(4):243–252.
  • Holmes ER, Tipton DJ, Desselle SP. The impact of the internet on community pharmacy practice: a comparison of a Delphi panel’s forecast with emerging trends. Health Mark Q. 2002;20(2):3–29.
  • Saramunee K, Krska J, Mackridge A, Richards J, Suttajit S, Phillips-Howard P. How to enhance public health service utilization in community pharmacy?: general public and health providers’ perspectives. Res Social Adm Pharm. 2014;10(2):272–284.
  • Blenkinsopp A, Bond C, Celino G, Inch J, Gray N. National evaluation of the new community pharmacy contract. Pharmacy Practice Research Trust. 2007. https://pharmacyresearchuk.org/wp-content/uploads/2012/11/National_evaluation_of_the_new_community_pharamcy_contract.pdf.